| Identification | More | [Name]
5-Fluoroisatin | [CAS]
443-69-6 | [Synonyms]
5-FLUORO-1H-INDOLE-2,3-DIONE
5-FLUOROINDOLE-2,3-DIONE
5-FLUOROINDOLINE-2,3-DIONE
5-FLUOROISATIN
5-FLUOROISATINE
AKOS BBS-00006537
BUTTPARK 24\07-36
5-Fluoroisatin,98%
5-Fluoroisatin 97%
5-FLUOROISATIN OR 5-FLUORO-1H-INDOLE-2,3-DIONE
5-Fluoroisatin97%
5-FLUOROISATIN 99+%
1H-Indole-2,3-dione, 5-fluoro-
5-FLUORO ISATINIC ANHYDRIDE
5-Fluoro-2,3-indoledione
NSC 39161 | [EINECS(EC#)]
628-890-1 | [Molecular Formula]
C8H4FNO2 | [MDL Number]
MFCD00022795 | [Molecular Weight]
165.12 | [MOL File]
443-69-6.mol |
| Chemical Properties | Back Directory | [Appearance]
red Crystalline Powder | [Melting point ]
224-227 °C (lit.) | [density ]
1.477±0.06 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,Room Temperature | [solubility ]
Chloroform, DMSO, Methanol | [form ]
Powder | [pka]
8.51±0.20(Predicted) | [color ]
Red | [Usage]
It showed antibacterial and antifungal activities.
| [BRN ]
131241 | [InChIKey]
GKODDAXOSGGARJ-UHFFFAOYSA-N | [CAS DataBase Reference]
443-69-6(CAS DataBase Reference) |
| Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S37/39:Wear suitable gloves and eye/face protection .
S36:Wear suitable protective clothing . | [WGK Germany ]
3
| [Hazard Note ]
Irritant | [HazardClass ]
IRRITANT | [HS Code ]
29337900 |
| Hazard Information | Back Directory | [Chemical Properties]
red Crystalline Powder | [Uses]
It showed antibacterial and antifungal activities.
| [Definition]
ChEBI: 5-Fluoroisatin is a member of indoles. It has a role as an anticoronaviral agent. | [General Description]
5-Fluoroisatin has been reported as the precursor of the Sunitinib (Sutent) drug. 5-Fluoroisatin has been approved by the Food and Drugs Administration (FDA) in 2006 for the treatment of renal cell carcinoma (RCC) and gastrointestinal stromal tumor (GIST). |
|
|